4//SEC Filing
Drape Eric 4
Accession 0000950170-24-025995
CIK 0000818686other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:25 PM ET
Size
11.0 KB
Accession
0000950170-24-025995
Insider Transaction Report
Form 4
Drape Eric
Executive VP Global Operations
Transactions
- Exercise/Conversion
Ordinary Shares
2024-03-03+24,900→ 44,416 total - Exercise/Conversion
Ordinary Shares
2024-03-04+33,512→ 77,928 total - Exercise/Conversion
Restricted Share Units
2024-03-03−24,900→ 74,701 total→ Ordinary Shares (24,900 underlying) - Exercise/Conversion
Restricted Share Units
2024-03-04−33,512→ 67,024 total→ Ordinary Shares (33,512 underlying)
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027.
- [F4]Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023 and March 4, 2024, and 33,512 vesting on each of March 4, 2025 and March 4, 2026.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001790905
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:25 PM ET
- Size
- 11.0 KB